Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Is the $1000 Genome as Near as We Think? A Cost Analysis of Next-Generation Sequencing.

van Nimwegen KJ, van Soest RA, Veltman JA, Nelen MR, van der Wilt GJ, Vissers LE, Grutters JP.

Clin Chem. 2016 Nov;62(11):1458-1464. Epub 2016 Sep 14.

2.

Translating sanger-based routine DNA diagnostics into generic massive parallel ion semiconductor sequencing.

Diekstra A, Bosgoed E, Rikken A, van Lier B, Kamsteeg EJ, Tychon M, Derks RC, van Soest RA, Mensenkamp AR, Scheffer H, Neveling K, Nelen MR.

Clin Chem. 2015 Jan;61(1):154-62. doi: 10.1373/clinchem.2014.225250. Epub 2014 Oct 1.

3.

Detection and functional analysis of CD8+ T cells specific for PRAME: a target for T-cell therapy.

Griffioen M, Kessler JH, Borghi M, van Soest RA, van der Minne CE, Nouta J, van der Burg SH, Medema JP, Schrier PI, Falkenburg JH, Osanto S, Melief CJ.

Clin Cancer Res. 2006 May 15;12(10):3130-6.

4.

Prognostic relevance of occult tumour cells in lymph nodes in colorectal cancer.

Doekhie FS, Kuppen PJ, Peeters KC, Mesker WE, van Soest RA, Morreau H, van de Velde CJ, Tanke HJ, Tollenaar RA.

Eur J Surg Oncol. 2006 Apr;32(3):253-8. Epub 2006 Jan 18. Review.

PMID:
16412600
5.

Up-regulated expression in nonhematopoietic tissues of the BCL2A1-derived minor histocompatibility antigens in response to inflammatory cytokines: relevance for allogeneic immunotherapy of leukemia.

Kloosterboer FM, van Luxemburg-Heijs SA, van Soest RA, van Egmond HM, Willemze R, Falkenburg JH.

Blood. 2005 Dec 1;106(12):3955-7. Epub 2005 Aug 11.

6.

Minor histocompatibility antigen-specific T cells with multiple distinct specificities can be isolated by direct cloning of IFNgamma-secreting T cells from patients with relapsed leukemia responding to donor lymphocyte infusion.

Kloosterboer FM, van Luxemburg-Heijs SA, van Soest RA, van Egmond HM, Barbui AM, Strijbosch MP, Willemze R, Falkenburg JH.

Leukemia. 2005 Jan;19(1):83-90.

PMID:
15526024
7.

Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.

Posthuma EF, Marijt EW, Barge RM, van Soest RA, Baas IO, Starrenburg CW, van Zelderen-Bhola SL, Fibbe WE, Smit WM, Willemze R, Falkenburg JH.

Biol Blood Marrow Transplant. 2004 Mar;10(3):204-12.

8.

Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells.

Kloosterboer FM, van Luxemburg-Heijs SA, van Soest RA, Barbui AM, van Egmond HM, Strijbosch MP, Kester MG, Marijt WA, Goulmy E, Willemze R, Falkenburg JH.

Leukemia. 2004 Apr;18(4):798-808.

PMID:
14973499
9.

The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.

Vogt MH, van den Muijsenberg JW, Goulmy E, Spierings E, Kluck P, Kester MG, van Soest RA, Drijfhout JW, Willemze R, Falkenburg JH.

Blood. 2002 Apr 15;99(8):3027-32.

10.

Sublocalization of the breakpoints of a t(5;16) in myelodysplasia.

van Soest RA, Bolk MW, Kluck PM, Janssen B, van Kessel AG, Wessels HW, Willemze R, Landegent JE.

Cancer Genet Cytogenet. 1998 Jan 1;100(1):5-9.

PMID:
9406573

Supplemental Content

Loading ...
Support Center